Leading experts, collaborating with us, develop a variety of educational programmes in the field of hemato-oncology. Explore the latest programmes to support your clinical decision-making.
A 3-part video series on managing early RRMM from leading medical experts
Medical experts discuss the latest learnings from clinical practice
Episode 6: Lymphoma Update: SWOG S1826 trial
Highlights from the ASH Annual Meeting
Dr Hans Lee summarises the highlights from the phase 3 DETERMINATION trial: Lenalidomide, bortezomib, and dexamethasone (RVd) ± autologous stem cell transplantation (ASCT) and R maintenance to progression for newly diagnosed multiple myeloma (NDMM)
Episode 3: Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics